Oren Gilad

2.3k total citations
23 papers, 1.9k citations indexed

About

Oren Gilad is a scholar working on Immunology, Molecular Biology and Animal Science and Zoology. According to data from OpenAlex, Oren Gilad has authored 23 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Molecular Biology and 6 papers in Animal Science and Zoology. Recurrent topics in Oren Gilad's work include Aquaculture disease management and microbiota (8 papers), Animal Virus Infections Studies (6 papers) and DNA Repair Mechanisms (5 papers). Oren Gilad is often cited by papers focused on Aquaculture disease management and microbiota (8 papers), Animal Virus Infections Studies (6 papers) and DNA Repair Mechanisms (5 papers). Oren Gilad collaborates with scholars based in United States, Israel and Italy. Oren Gilad's co-authors include Hervé Bercovier, Ronald P. Hedrick, S Yun, Avi Eldar, RP Hedrick, Mark Adkison, Myron J. Kebus, Gary D. Marty, Robert W. Nordhausen and Eric J. Brown and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Oren Gilad

23 papers receiving 1.7k citations

Peers

Countries citing papers authored by Oren Gilad

Since Specialization

Citations

This map shows the geographic impact of Oren Gilad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oren Gilad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oren Gilad more than expected).

Fields of papers citing papers by Oren Gilad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oren Gilad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oren Gilad. The network helps show where Oren Gilad may publish in the future.

Co-authorship network of co-authors of Oren Gilad

This figure shows the co-authorship network connecting the top 25 collaborators of Oren Gilad. A scholar is included among the top collaborators of Oren Gilad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oren Gilad. Oren Gilad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 7121: The novel WEE1i, APR-1051, is a potentially well tolerated and effective treatment for cyclin E-overexpressing cancers 2024 ·Cancer Research ·(unknown), (unknown), (unknown), Joseph P. Vacca, (unknown), Jonathan D. Weinstein, (unknown), (unknown), Michael Carleton, Eric J. Brown, Oren Gilad	2
2	Abstract C147: The DNA replication checkpoint inhibitors, ATRN-1051 (WEE1i) and ATRN-119 (ATRi), are potentially well tolerated and effective cancer treatments 2023 ·Molecular Cancer Therapeutics ·Joseph P. Vacca, (unknown), (unknown), (unknown), (unknown), Fiona Simpkins, Eric J. Brown, Oren Gilad	1
3	Synthetic-lethal interactions between ATR inhibition and functional genetic and proteomic biomarkers to predict responses in endometriosis-associated cancers. 2020 ·Journal of Clinical Oncology ·Oren Gilad, (unknown), Erin George, Rakesh Chettier, Fiona Simpkins, (unknown), Eric J. Brown	2
4	Temozolomide Sensitizes MGMT-Deficient Tumor Cells to ATR Inhibitors 2019 ·Cancer Research ·Christopher Jackson, Seth Noorbakhsh, Ranjini K. Sundaram, (unknown), (unknown), (unknown), (unknown), Danielle M. Burgenske, Oren Gilad, Jann N. Sarkaria, Ranjit S. Bindra	45
5	Abstract 3498: Highly specific macrocyclic ATR inhibitors for the targeted treatment of a broad spectrum of cancers showing lack of anemia or neutropenia in pre-clinical animal models 2019 ·Sahithi Pamarthy, (unknown), (unknown), Tina Gill, (unknown), Erin George, Laura Butler, Ryan L. Ragland, (unknown), Fiona Simpkins, Eric J. Brown, Oren Gilad	1
6	Improving the efficacy of PARP inhibition with a novel ATR inhibitor, ATRN119, in ovarian high-grade serous cancers 2018 ·Gynecologic Oncology ·Erin George, (unknown), Laura Butler, Mark A. Morgan, Oren Gilad, (unknown), Fiona Simpkins	3
7	Abstract 1226: Highly specific ATR inhibitors as a therapeutic approach for a broad spectrum of cancers 2016 ·Cancer Research ·Laura Butler, Ryan L. Ragland, (unknown), (unknown), Erin George, Fiona Simpkins, Eric J. Brown, Oren Gilad	1
8	Oncogenic stress sensitizes murine cancers to hypomorphic suppression of ATR 2011 ·Journal of Clinical Investigation ·David W. Schoppy, Ryan L. Ragland, Oren Gilad, (unknown), (unknown), Matilde Murga, Óscar Fernández-Capetillo, J. Alan Diehl, Eric J. Brown	137
9	Multidrug resistance protein (MRP) 4 attenuates benzo[a]pyrene-mediated DNA-adduct formation in human bronchoalveolar H358 cells 2011 ·Toxicology Letters ·Stacy L. Gelhaus, Oren Gilad, Wei‐Ting Hwang, T.M. Penning, Ian A. Blair	14
10	Combining ATR Suppression with Oncogenic Ras Synergistically Increases Genomic Instability, Causing Synthetic Lethality or Tumorigenesis in a Dosage-Dependent Manner 2010 ·Cancer Research ·Oren Gilad, Barzin Y. Nabet, Ryan L. Ragland, David W. Schoppy, Kevin D. Smith, Amy C. Durham, Eric J. Brown	173
11	Homodimerization of Marek's Disease Virus-Encoded Meq Protein Is Not Sufficient for Transformation of Lymphocytes in Chickens 2008 ·Journal of Virology ·(unknown), Yoshihiro Izumiya, Blanca Lupiani, Dharani K. Ajithdoss, Oren Gilad, Lucy F. Lee, Hsing-Jien Kung, Sanjay M. Reddy	33
12	BCL‐2 functions as an activator of the AKT signaling pathway in pancreatic cancer 2007 ·Journal of Cellular Biochemistry ·Melinda M. Mortenson, (unknown), Oren Gilad, Michael G. Schlieman, Subbulakshmi Virudachalam, Hsing‐Jien Kung, Richard J. Bold	42
13	Cloning of the koi herpesvirus (KHV) gene encoding thymidine kinase and its use for a highly sensitive PCR based diagnosis 2005 ·BMC Microbiology ·Hervé Bercovier, Yolanta Fishman, (unknown), (unknown), Amir Zlotkin, Marina Eyngor, Oren Gilad, Avi Eldar, Ronald P. Hedrick	139
14	An Enzyme Linked Immunosorbent Assay (ELISA) for Detection of Antibodies to the Koi Herpesvirus (KHV) in the Serum of Koi Cyprinus carpio 2005 ·Fish Pathology ·Mark Adkison, Oren Gilad, Ronald P. Hedrick	69
15	Initial Isolation and Characterization of a Herpes-like Virus (KHV) from Koi and Common Carp (Special Issue: International Symposium on Koi Herpesvirus disease) 2005 ·Medical Entomology and Zoology ·Ronald P. Hedrick, Oren Gilad, Susan Yun	1
16	Initial isolation and characterization of a herpes-like virus (KHV) from koi and common carp 2005 ·Ronald P. Hedrick, Oren Gilad, (unknown), T. McDowell, Thomas B. Waltzek, Garry O. Kelley, (unknown)	48
17	Concentrations of a Koi herpesvirus (KHV) in tissues of experimentally-infected Cyprinus carpio koi as assessed by real-time TaqMan PCR 2004 ·Diseases of Aquatic Organisms ·Oren Gilad, S Yun, (unknown), (unknown), Hervé Bercovier, RP Hedrick	283
18	Systemic herpes-like virus in catfishIctalurus melas(Italy) differs from Ictalurid herpesvirus 1 (North America) 2003 ·Diseases of Aquatic Organisms ·RP Hedrick, (unknown), Oren Gilad, (unknown), G. Bovo	18
19	Initial characteristics of koi herpesvirus and development of a polymerase chain reaction assay to detect the virus in koi, Cyprinus carpio koi 2002 ·Diseases of Aquatic Organisms ·Oren Gilad, S Yun, Karl B. Andrée, (unknown), Amir Zlotkin, Hervé Bercovier, Avi Eldar, RP Hedrick	168
20	A Herpesvirus Associated with Mass Mortality of Juvenile and Adult Koi, a Strain of Common Carp 2000 ·Journal of Aquatic Animal Health ·Ronald P. Hedrick, Oren Gilad, S Yun, (unknown), Gary D. Marty, Robert W. Nordhausen, Myron J. Kebus, Hervé Bercovier, Avi Eldar	399

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact